Polygenic Risk Score Services Market Report 2026

Polygenic Risk Score Services Market Overview

• Polygenic Risk Score Services market size has reached to $1.45 billion in 2025 • Expected to grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 16.4% • Growth Driver: Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches • Market Trend: Advancing Preventive And Precision Health Through Genomic Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polygenic Risk Score Services Market?

Polygenic risk score (PRS) services refers to solutions that calculate an individual’s likelihood of developing certain diseases or conditions based on the combined effect of multiple genetic variants across the genome. These services analyze DNA data, often from genotyping or sequencing, and apply statistical models to generate a risk score. The main service types of polygenic risk score services are genotyping, sequencing, data analysis, reporting, and others. Genotyping is the process of determining differences in the genetic makeup (genotype) of an individual by examining their DNA sequence using biological assays. These services find applications in disease risk assessment, personalized medicine, research, and others, serving major end-users including hospitals and clinics, research institutes, direct-to-consumer providers, and others.

What Is The Polygenic Risk Score Services Market Growth Forecast?

The polygenic risk score services market size is expected to see rapid growth in the next few years. It will grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increasing clinical adoption of risk stratification tools, rising integration of prs into personalized medicine, expansion of preventive genomics programs, growing demand for interoperable genetic data platforms, increasing regulatory clarity for genetic services. Major trends in the forecast period include increasing adoption of polygenic risk prediction algorithms, rising integration of prs with clinical decision tools, growing demand for population-specific risk models, expansion of direct-to-consumer genetic risk services, enhanced focus on data security and privacy.

Global Polygenic Risk Score Services Market Segmentation

1) By Service Type: Genotyping, Sequencing, Data Analysis, Reporting, Other Service Types 2) By Application: Disease Risk Assessment, Personalized Medicine, Research, Other Applications 3) By End-User: Hospitals And Clinics, Research Institutes, Direct-to-Consumer, Other End-Users Subsegments: 1) By Genotyping: Array-Based Genotyping, Targeted Genotyping, High-Throughput Genotyping 2) By Sequencing: Whole Genome Sequencing (Wgs), Whole Exome Sequencing (Wes), Targeted Sequencing 3) By Data Analysis: Polygenic Risk Prediction Algorithms, Bioinformatics And Statistical Analysis, Data Integration With Electronic Health Records (Ehr) 4) By Reporting: Clinical Reports For Healthcare Providers, Direct-To-Consumer (Dtc) Reports, Risk Stratification Reports (Disease-Specific) 5) By Other Service Types: Genetic Counseling Services, Data Storage And Cloud-Based Platforms, Prs Software And Toolkits

What Is The Driver Of The Polygenic Risk Score Services Market?

The growing emphasis on personalized medicine is expected to propel the growth of the polygenic risk score (PRS) services market going forward. Personalized medicine refers to a healthcare approach that tailors prevention, diagnosis, and treatment decisions to an individual’s genetic, environmental, and lifestyle factors. Personalized medicine is increasing due to advances in genomics that enable deeper insight into individual genetic variations, supporting more precise and targeted therapeutic strategies. The polygenic risk score services market supports this driver by analyzing multiple genetic variants to estimate disease risk, enabling clinicians to design personalized prevention strategies, early interventions, and customized treatment plans based on each patient’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022, alongside seven personalized cancer drugs and three treatments for other conditions. Therefore, the growing emphasis on personalized medicine is driving the growth of the polygenic risk score services industry.

Key Players In The Global Polygenic Risk Score Services Market

Major companies operating in the polygenic risk score services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Illumina Inc., Endeavor Health Inc., Myriad Genetics Inc., The Broad Institute of MIT and Harvard, BGI Group, Invitae Corporation, 23andMe Holding Co., Color Health Inc., Genomics Ltd., Cogentech S.R.L., Gene by Gene Ltd., Our Future Health Ltd., Mapmygenome India Limited, Australian Genome Research Facility (AGRF) Ltd., Golden Helix Inc., Allelica Inc., Antegenes OÜ, GeninCode Plc

Global Polygenic Risk Score Services Market Trends and Insights

Major companies operating in the polygenic risk score services market are focusing on developing innovative solutions such as pharmacogenomics to enhance personalized treatment strategies and improve patient outcomes. Pharmacogenomics refers to the study of how an individual’s genetic makeup influences their response to drugs, enabling more precise and personalized treatment. For instance, in July 2025, Bupa, a UK-based health insurance company, launched a new suite of DNA-based tests to support personalized health and wellness insights. This suit offers personalized insights on medication response and disease risk, enabling earlier detection and tailored treatment for conditions such as cancer, diabetes, and heart disease. These tests help prevent side effects, improve long-term health outcomes, and empower individuals to take proactive steps for themselves and their families. The purpose is to shift healthcare from reactive treatment to preventive, precision health management.

What Are Latest Mergers And Acquisitions In The Polygenic Risk Score Services Market?

In May 2024, GSK Plc, a UK-based pharmaceutical company, partnered with Genomics Ltd. to advance genetic research and develop personalized therapies. This partnership aims to leverage polygenic risk scores to optimize clinical trial design by selecting the right patients, thereby reducing trial size and duration while enhancing drug development efficiency. Genomics Ltd. is a UK-based precision medicine company that provides polygenic risk score services.

Regional Outlook

North America was the largest region in the polygenic risk score services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polygenic Risk Score Services Market?

The polygenic risk score (PRS) services market includes revenues earned by entities providing services such as polygenic risk scoring, genetic testing, data analysis and interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Polygenic Risk Score Services Market Report 2026?

The polygenic risk score services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polygenic risk score services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.